← Leaderboards
Jay A Nelson
Oregon Health & Science University
$38,488,581
Attributed
$40,419,463
Total exposure
50
Grants
36
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.2M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$92,688,642 · 52
By mechanism
U54$43,290,096 · 2
R01$19,161,174 · 6
P01$17,554,791 · 6
U19$5,904,548 · 2
R37$3,313,965 · 1
P51$1,160,143 · 14
Top collaborators
- Andrew D Yurochko6 shared
- William J Britt5 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- David C. Johnson$20,134,941
- Adam L Vanarsdall$423,500
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- William J Britt · University Of Alabama At Birmingham$26,516,154
Research focus
CytomegalovirusCellsViralVirusInfectionImmuneGenesMicrornasHerpesviridaeBaseProteinsGene ExpressionMacrophageMolecularSignal PathwayMutantMutationVirus ReplicationPathogenComplexRegulationFundingTransplant RecipientsResponse
Grant awards (147)
HCMV miRNA regulation of host cell signaling in viral latency and reactivation$370,388
P01 · FY2025 · AI · contact PI
The Administrative Core$120,578
P01 · FY2025 · AI · contact PI
HCMV miRNA regulation of host cell signaling in viral latency and reactivation$444,396
P01 · FY2024 · AI · contact PI
The Administrative Core$130,916
P01 · FY2024 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$639,040
R37 · FY2023 · AI · contact PI
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation$2,605,842
P01 · FY2022 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$532,285
R37 · FY2022 · AI · contact PI
HCMV miRNA regulation of host cell signaling in viral latency and reactivation$430,307
P01 · FY2022 · AI · contact PI
The Administrative Core$130,917
P01 · FY2022 · AI · contact PI
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency, reactivation, and hematopoiesis during transplantation$1,808,089
P01 · FY2021 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$532,285
R37 · FY2021 · AI · contact PI
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of Vector Tropism$401,970
U19 · FY2021 · AI · contact PI
HCMV miRNA regulation of host cell signaling in viral latency and hematopoiesis$268,818
P01 · FY2021 · AI · contact PI
Administrative Core$72,572
P01 · FY2021 · AI · contact PI
International Herpesvirus Workshop$10,000
R13 · FY2021 · AI · contact PI
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency, reactivation, and hematopoiesis during transplantation$1,814,596
P01 · FY2020 · AI · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2020 · AI
Molecular Aspects of Cytomegalovirus Latency$532,285
R37 · FY2020 · AI · contact PI
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of Vector Tropism$371,423
U19 · FY2020 · AI · contact PI
HCMV miRNA regulation of host cell signaling in viral latency and hematopoiesis$270,775
P01 · FY2020 · AI · contact PI
Administrative Core$87,080
P01 · FY2020 · AI · contact PI
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency, reactivation, and hematopoiesis during transplantation$1,820,785
P01 · FY2019 · AI · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2019 · AI
Molecular Aspects of Cytomegalovirus Latency$532,285
R37 · FY2019 · AI · contact PI
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of Vector Tropism$371,424
U19 · FY2019 · AI · contact PI
HCMV miRNA regulation of host cell signaling in viral latency and hematopoiesis$265,732
P01 · FY2019 · AI · contact PI
Administrative Core$87,080
P01 · FY2019 · AI · contact PI
International Herpesvirus Workshop$7,500
R13 · FY2019 · AI · contact PI
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency, reactivation, and hematopoiesis during transplantation$1,823,847
P01 · FY2018 · AI · contact PI
Identification and Development of Anti-Flavivirus Lead Drug Candidates$804,520
U19 · FY2018 · AI · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2018 · AI
Molecular Aspects of Cytomegalovirus Latency$545,785
R37 · FY2018 · AI · contact PI
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of Vector Tropism$371,424
U19 · FY2018 · AI · contact PI
HCMV miRNA regulation of host cell signaling in viral latency and hematopoiesis$267,686
P01 · FY2018 · AI · contact PI
Administrative Core$93,325
P01 · FY2018 · AI · contact PI
International Herpesvirus Workshop$9,000
R13 · FY2018 · AI · contact PI
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency, reactivation, and hematopoiesis during transplantation$2,000,000
P01 · FY2017 · AI · contact PI
Identification and Development of Anti-Flavivirus Lead Drug Candidates$947,621
U19 · FY2017 · AI · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2017 · AI
Molecular Aspects of Cytomegalovirus Latency$499,607
R01 · FY2017 · AI · contact PI
HCMV miRNA regulation of host cell signaling in viral latency and hematopoiesis$305,312
P01 · FY2017 · AI · contact PI
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of Vector Tropism$304,680
U19 · FY2017 · AI · contact PI
Administrative Core$107,017
P01 · FY2017 · AI · contact PI
International Herpesvirus Workshop$6,500
R13 · FY2017 · AI · contact PI
Identification and Development of Anti-Flavivirus Lead Drug Candidates$838,268
U19 · FY2016 · AI · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$779,109
R01 · FY2016 · AI
Molecular Aspects of Cytomegalovirus Latency$499,607
R01 · FY2016 · AI · contact PI
Attenuation of CMV Vector Pathogenicity and Transmission by Altering Viral Tropis$384,764
P01 · FY2016 · AI · contact PI
International Herpesvirus Workshop$8,000
R13 · FY2016 · AI · contact PI
Identification and Development of Anti-Flavivirus Lead Drug Candidates$780,709
U19 · FY2015 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$499,607
R01 · FY2015 · AI · contact PI
Attenuation of CMV Vector Pathogenicity and Transmission by Altering Viral Tropis$334,493
P01 · FY2015 · AI · contact PI
International Herpesvirus Workshop$6,000
R13 · FY2015 · AI · contact PI
Identification and Development of Anti-Flavivirus Lead Drug Candidates$712,509
U19 · FY2014 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$499,607
R01 · FY2014 · AI · contact PI
Attenuation of CMV Vector Pathogenicity and Transmission by Altering Viral Tropis$287,403
P01 · FY2014 · AI · contact PI
International Herpesvirus Workshop$8,000
R13 · FY2014 · AI · contact PI
Pacific NorthWest Regional Center of Excellence (PNWRCE)$7,230,475
U54 · FY2013 · AI · contact PI
Administrative Core$610,013
U54 · FY2013 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$488,382
R01 · FY2013 · AI · contact PI
Attenuation of CMV Vector Pathogenicity and Transmission by Altering Viral Tropis$343,962
P01 · FY2013 · AI · contact PI
Training Program in Virology$185,222
T32 · FY2013 · AI · contact PI
International Herpesvirus Workshop$4,000
R13 · FY2013 · AI · contact PI
Pacific NorthWest Regional Center of Excellence (PNWRCE)$7,798,614
U54 · FY2012 · AI · contact PI
The role of CMV secretome in the acceleration of transplant vascular sclerosis$636,275
R01 · FY2012 · HL · contact PI
Administrative Core$599,828
U54 · FY2012 · AI · contact PI
Attenuation of CMV Vector Pathogenicity and Transmission by Altering Viral Tropis$427,244
P01 · FY2012 · AI · contact PI
Training Program in Virology$215,262
T32 · FY2012 · AI · contact PI
International Herpesvirus Workshop$6,000
R13 · FY2012 · AI · contact PI
Pacific NorthWest Regional Center of Excellence (PNWRCE)$8,113,612
U54 · FY2011 · AI · contact PI
The role of CMV secretome in the acceleration of transplant vascular sclerosis$765,953
R01 · FY2011 · HL · contact PI
Administrative Core$570,915
U54 · FY2011 · AI · contact PI
Attenuation of CMV Vector Pathogenicity and Transmission by Altering Viral Tropis$450,867
P01 · FY2011 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$370,170
R01 · FY2011 · AI · contact PI
Training Program in Virology$234,303
T32 · FY2011 · AI · contact PI
International Herpesvirus Workshop$10,000
R13 · FY2011 · AI · contact PI
Pacific NorthWest Regional Center of Excellence (PNWRCE)$8,064,974
U54 · FY2010 · AI · contact PI
The role of CMV secretome in the acceleration of transplant vascular sclerosis$732,525
R01 · FY2010 · HL · contact PI
Strategic Plan and Management$553,045
U54 · FY2010 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$373,909
R01 · FY2010 · AI · contact PI
Training Program in Virology$231,159
T32 · FY2010 · AI · contact PI
ROLE OF THE CYTOMEGALOVIRUS SECRETOME IN ACCELERATION OF TVS$95,066
P51 · FY2010 · RR · contact PI
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$76,080
P51 · FY2010 · RR · contact PI
International Herpesvirus Workshop$17,000
R13 · FY2010 · CA · contact PI
Pacific NorthWest Regional Center of Excellence (PNWRCE)$8,368,696
U54 · FY2009 · AI · contact PI
Pacific NorthWest Regional Center of Excellence (PNWRCE)$819,649
U54 · FY2009 · AI · contact PI
The role of CMV secretome in the acceleration of transplant vascular sclerosis$728,481
R01 · FY2009 · HL · contact PI
Strategic Plan and Management$560,275
U54 · FY2009 · AI · contact PI
Molecular Aspects of Cytomegalovirus Latency$377,685
R01 · FY2009 · AI · contact PI
Training Program in Virology$229,506
T32 · FY2009 · AI · contact PI
CHEMOKINE RECEPTORS IN VASCULAR DISEASE$80,343
P51 · FY2009 · RR · contact PI
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$80,343
P51 · FY2009 · RR · contact PI
The role of CMV secretome in the acceleration of transplant vascular sclerosis$765,302
R01 · FY2008 · HL · contact PI
Molecular Aspects of Cytomegalovirus Latency$377,685
R01 · FY2008 · AI · contact PI
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$55,512
P51 · FY2008 · RR · contact PI
CHEMOKINE RECEPTORS IN VASCULAR DISEASE$55,512
P51 · FY2008 · RR · contact PI
DETERMINING THE INFLUENCES OF HCMV INFECTION IN VASCULAR SCLEROSIS$24,012
P41 · FY2008 · RR · contact PI
33rd International Herpesvirus Workshop$19,000
R13 · FY2008 · CA · contact PI
Molecular Aspects of Cytomegalovirus Latency$385,000
R01 · FY2007 · AI · contact PI
Chemokine Receptors in Vascular Disease$357,938
R01 · FY2007 · HL · contact PI
THE CELLULAR BASIS OF CMV ACCELERATED VASCULOPATHY$113,873
P51 · FY2007 · RR · contact PI
PROTEOMIC CHARACTERIZATION OF SPECIFIC HCMV PROTEIN-HOST PROTEIN INTERACTIONS$41,969
P41 · FY2007 · RR · contact PI
28th International Herpesvirus Workshop,$21,923
R13 · FY2007 · CA · contact PI
Chemokine Receptors in Vascular Disease$368,629
R01 · FY2006 · HL · contact PI
Molecular Aspects of Cytomegalovirus Latency$368,629
R01 · FY2006 · AI · contact PI
THE ROLE OF SRC KINASE IN WEST NILE VIRUS REPLICATION$76,828
P51 · FY2006 · RR · contact PI
THE CELLULAR BASIS OF CMV ACCELERATED VASCULOPATHY$76,828
P51 · FY2006 · RR · contact PI
PROTEOMIC CHARACTERIZATION OF SPECIFIC HCMV PROTEIN-HOST PROTEIN INTERACTIONS$42,030
P41 · FY2006 · RR · contact PI
28th International Herpesvirus Workshop,$30,648
R13 · FY2006 · CA · contact PI
Cellular Basis of CMV Accelerated Vasculopathy$377,500
R01 · FY2005 · HL
Chemokine Receptors in Vascular Disease$377,500
R01 · FY2005 · HL
Molecular Aspects of Cytomegalovirus Latency$377,500
R01 · FY2005 · AI
The Role of Src Kinase in West Nile Virus Replication$226,500
R21 · FY2005 · AI
THE ROLE OF SRC KINASE IN WEST NILE VIRUS REPLICATION$74,664
P51 · FY2005 · RR
PROTEOMIC CHARACTERIZATION OF SPECIFIC HCMV PROTEIN-HOST PROTEIN INTERACTIONS$38,851
P41 · FY2005 · RR
28th International Herpesvirus Workshop,$13,000
R13 · FY2005 · CA
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$12,458
M01 · FY2005 · RR
Cellular Basis of CMV Accelerated Vasculopathy$377,500
R01 · FY2004 · HL
Chemokine Receptors in Vascular Disease$377,500
R01 · FY2004 · HL
Molecular Aspects of Cytomegalovirus Latency$377,500
R01 · FY2004 · AI
The Role of Src Kinase in West Nile Virus Replication$226,500
R21 · FY2004 · AI
PROTEOMIC CHARACTERIZATION OF SPECIFIC HCMV PROTEIN-HOST PROTEIN INTERACTIONS$106,838
P41 · FY2004 · RR
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$82,173
P51 · FY2004 · RR
CHEMOKINE RECEPTORS IN VASCULAR DISEASE$82,173
P51 · FY2004 · RR
THE CELLULAR BASIS OF CMV ACCELERATED VASCULOPATHY$82,173
P51 · FY2004 · RR
28th International Herpesvirus Workshop,$30,000
R13 · FY2004 · CA
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$12,833
M01 · FY2004 · RR
Cellular Basis of CMV Accelerated Vasculopathy$377,500
R01 · FY2003 · HL
Molecular Aspects of Cytomegalovirus Latency$377,500
R01 · FY2003 · AI
CHEMOKINE RECEPTORS IN VASCULAR DISEASE$300,470
R01 · FY2003 · HL
28th International Herpesvirus Workshop,$33,500
R13 · FY2003 · CA
Cellular Basis of CMV Accelerated Vasculopathy$377,500
R01 · FY2002 · HL
Molecular Aspects of Cytomegalovirus Latency$339,750
R01 · FY2002 · AI
CHEMOKINE RECEPTORS IN VASCULAR DISEASE$300,470
R01 · FY2002 · HL
International Herpesvirus Workshop, Cairns, Australia$24,000
R13 · FY2002 · CA
BLOOD BRAIN BARRIER DYSFUNCTION--AIDS NEUROLOGIC DISEASE$342,542
R01 · FY2001 · MH
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$301,737
R01 · FY2001 · AI
CHEMOKINE RECEPTORS IN VASCULAR DISEASE$300,470
R01 · FY2001 · HL
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$172,411
M01 · FY2001 · RR
26th Intl Herpesvirus Workshop, Regensburg, Germany$20,000
R13 · FY2001 · CA
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$0
M01 · FY2001 · RR
BLOOD BRAIN BARRIER DYSFUNCTION--AIDS NEUROLOGIC DISEASE$332,567
R01 · FY2000 · MH
CHEMOKINE RECEPTORS IN VASCULAR DISEASE$295,880
R01 · FY2000 · HL
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$293,032
R01 · FY2000 · AI
RESERVOIRS OF SIV IN CNS &BONE MARROW$128,575
P51 · FY2000 · RR
25TH INTERNATIONAL HERPESVIRUS WORKSHOP$20,000
R13 · FY2000 · CA
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCY$0
M01 · FY2000 · RR